Found 7 matching trials
Relative Bioavailability Study for GSK1278863A
PHASE1A randomized, open-label, 3-period crossover study....
Location
GSK Investigational Site
Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers
PHASE1This protocol is designed to explore whether short-term therapy with GSK127...
Location
GSK Investigational Site
Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia
PHASE2The purpose of this study is to characterize the safety and efficacy of rep...
Location
GSK Investigational Site
Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment
PHASE1The purpose of this study is to characterize the safety and tolerability of...
Location
GSK Investigational Site
Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)
PHASE1Study to Assess the Pharmacokinetics of GSK1278863A Coadministered with a H...
Location
GSK Investigational Site
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects
PHASE1A first-time in human study to investigate the safety, tolerability, pharma...
Location
GSK Investigational Site
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects
PHASE1GSK1278863A is a novel small molecule agent, which stimulates erythropoiesi...
Location
GSK Investigational Site